Co-Targeting the EGFR and PI3K/Akt Pathway to Overcome Therapeutic Resistance in Head and Neck Squamous Cell Carcinoma: What about Autophagy?

por Zaryouh, Hannah, Van Loenhout, Jinthe, Peeters, Marc, Vermorken, Jan Baptist, Lardon, Filip, Wouters, An
Publicado 2022

Head and Neck Cancer

por Psyrri, Amanda, Burtness, Barbara, Harari, Paul M., Vermorken, Jan Baptist, Licitra, Lisa, Sasaki, Clarence T.
Publicado 2009

Editorial: Advances in the Pathogenesis and Therapeutic Strategies for Nasopharyngeal Carcinoma

por Yang, Kai-Bin, Xu, Cheng, Chen, Yu-Pei, Vermorken, Jan Baptist, O'Sullivan, Brian, Ma, Jun
Publicado 2021

The Role of Akt in Acquired Cetuximab Resistant Head and Neck Squamous Cell Carcinoma: An In Vitro Study on a Novel Combination Strategy

por Zaryouh, Hannah, De Pauw, Ines, Baysal, Hasan, Pauwels, Patrick, Peeters, Marc, Vermorken, Jan Baptist, Lardon, Filip, Wouters, An
Publicado 2021

The Right Partner in Crime: Unlocking the Potential of the Anti-EGFR Antibody Cetuximab via Combination With Natural Killer Cell Chartering Immunotherapeutic Strategies

por Baysal, Hasan, De Pauw, Ines, Zaryouh, Hannah, Peeters, Marc, Vermorken, Jan Baptist, Lardon, Filip, De Waele, Jorrit, Wouters, An
Publicado 2021

Overcoming Intrinsic and Acquired Cetuximab Resistance in RAS Wild-Type Colorectal Cancer: An In Vitro Study on the Expression of HER Receptors and the Potential of Afatinib

por De Pauw, Ines, Lardon, Filip, Van den Bossche, Jolien, Baysal, Hasan, Pauwels, Patrick, Peeters, Marc, Vermorken, Jan Baptist, Wouters, An
Publicado 2019

Simultaneous targeting of EGFR, HER2, and HER4 by afatinib overcomes intrinsic and acquired cetuximab resistance in head and neck squamous cell carcinoma cell lines

por De Pauw, Ines, Lardon, Filip, Van den Bossche, Jolien, Baysal, Hasan, Fransen, Erik, Deschoolmeester, Vanessa, Pauwels, Patrick, Peeters, Marc, Vermorken, Jan Baptist, Wouters, An
Publicado 2018

Cetuximab-induced natural killer cell cytotoxicity in head and neck squamous cell carcinoma cell lines: investigation of the role of cetuximab sensitivity and HPV status

por Baysal, Hasan, De Pauw, Ines, Zaryouh, Hannah, De Waele, Jorrit, Peeters, Marc, Pauwels, Patrick, Vermorken, Jan Baptist, Smits, Evelien, Lardon, Filip, Jacobs, Julie, Wouters, An
Publicado 2020

Radiosensitization of Non-Small Cell Lung Cancer Cells by the Plk1 Inhibitor Volasertib Is Dependent on the p53 Status

por Van den Bossche, Jolien, Domen, Andreas, Peeters, Marc, Deben, Christophe, De Pauw, Ines, Jacobs, Julie, De Bruycker, Sven, Specenier, Pol, Pauwels, Patrick, Vermorken, Jan Baptist, Lardon, Filip, Wouters, An
Publicado 2019

In vitro study of the Polo‐like kinase 1 inhibitor volasertib in non‐small‐cell lung cancer reveals a role for the tumor suppressor p53

por Van den Bossche, Jolien, Deben, Christophe, De Pauw, Ines, Lambrechts, Hilde, Hermans, Christophe, Deschoolmeester, Vanessa, Jacobs, Julie, Specenier, Pol, Pauwels, Patrick, Vermorken, Jan Baptist, Peeters, Marc, Lardon, Filip, Wouters, An
Publicado 2019

Towards Prognostic Profiling of Non-Small Cell Lung Cancer: New Perspectives on the Relevance of Polo-Like Kinase 1 Expression, the TP53 Mutation Status and Hypoxia

por Van den Bossche, Jolien, Deben, Christophe, Op de Beeck, Ken, Deschoolmeester, Vanessa, Hermans, Christophe, De Pauw, Ines, Jacobs, Julie, Van Schil, Paul, Vermorken, Jan Baptist, Pauwels, Patrick, Peeters, Marc, Lardon, Filip, Wouters, An
Publicado 2017

The prognostic impact of the immune signature in head and neck squamous cell carcinoma

por Baysal, Hasan, Siozopoulou, Vasiliki, Zaryouh, Hannah, Hermans, Christophe, Lau, Ho Wa, Lambrechts, Hilde, Fransen, Erik, De Pauw, Ines, Jacobs, Julie, Peeters, Marc, Pauwels, Patrick, Vermorken, Jan Baptist, Smits, Evelien, Lardon, Filip, De Waele, Jorrit, Wouters, An
Publicado 2022